Back to OREX Stock Lookup

OREX Related Analyst Ratings

Feb 4, 2013 10:45 AM VIVUS, Inc. (VVUS) Qsymia Prescriptions Show Gains During Slow Holiday Week (ARNA) (OREX)

Jan 17, 2013 07:41 AM Brean Capital Downgrades Vivus (VVUS) to Sell, Low Qsymia Coverage Means Low Sales

Jan 3, 2013 04:50 PM Piper Jaffray Starts Orexigen Therapeutics (OREX) at Overweight

Dec 21, 2012 11:56 AM JPMorgan Confident Orexigen's (OREX) Will Receive FDA Approval; Comments on Meeting

Dec 18, 2012 03:23 PM Orexigen (OREX) Slumps as Many Expected 'Better News' for Contrave

Dec 10, 2012 09:10 AM VIVUS (VVUS) Qsymia Prescriptions Pop Following Thanksgiving Glut (ARNA) (OREX)

Oct 31, 2012 02:18 PM Latest Qsymia Data Shapes Up Potential Bear Case for VIVUS (VVUS) and Peers (ARNA) (OREX)

Oct 23, 2012 07:42 AM Jefferies Boosts Target on Orexigen (OREX) as FDA Gets Close to Admitting Error

Oct 22, 2012 10:08 AM VIVUS (VVUS) Qsymia Prescriptions Keep Chugging, Gain 27%+ Last Week

Oct 8, 2012 12:48 PM VIVUS' (VVUS) Qsymia Prescription Insurer Pay Rate Rose 5% in Week Two

Sep 21, 2012 12:19 PM Not Expecting E.U. Approval for Vivus' (VVUS) Qsiva, Could be a Plus for Orexigen (OREX) - Analyst

Sep 6, 2012 03:42 PM Orexigen (OREX) Surges On 'Aggressive' Buy Calls Ahead of Catalysts

Sep 5, 2012 05:18 PM Credit Suisse Starts Orexigen Therapeutics (OREX) at Outperform

Jul 18, 2012 08:51 AM VIVUS's (VVUS) Qsymia Approval a Clear Positive for Orexigen (OREX) - Leerink

Jul 16, 2012 11:09 AM VIVUS (VVUS) Gets a Boost from Uber-Bullish Orexigen (OREX) Call

Jul 16, 2012 06:55 AM Leerink Swann Resumes Orexigen Therapeutics (OREX) at Outperform

Jul 13, 2012 08:43 AM With Plenty of Good Arguments for Both Bulls and Bears, VIVUS (VVUS) Qnexa Approval at 50/50 - Jefferies

Jun 28, 2012 03:39 PM UPDATE: JPMorgan Upgrades Orexigen Therapeutics (OREX) to Overweight, Best Opportunity in Obesity Space

Jun 28, 2012 10:21 AM Canaccord Genuity Morning Coffee on Arena Pharma. (ARNA): Does This Mean I Can Keep Eating Super-Sized Double Big Mac Meals?

Mar 26, 2012 10:54 AM Leerink Swann Says Orexigen (OREX) is Still the Best Play After Obesity Drug CV Study Briefing Documents, Boosts Target (VVUS)

Mar 12, 2012 09:02 AM Orexigen Therapeutics (OREX) Surges on BofA Upgrade

Mar 12, 2012 06:58 AM BofA/Merrill Lynch Upgrades Orexigen Therapeutics (OREX) to Buy

Feb 23, 2012 11:20 AM Leerink Swann: Buyers of Orexigen Therapeutics (OREX) Into Next Panel; Preferred Small/Midcap Biotech Pick

Dec 16, 2011 10:10 AM Lazard Capital Upgrades Orexigen Therapeutics (OREX) to Neutral

Nov 21, 2011 05:33 PM Collins Stewart Starts BioMimetic Therapeutics (BMTI) at Buy, Price Target Calls for 143% Upside

Sep 23, 2011 12:51 PM Jefferies Raises Price Target on Orexigen Therapeutics (OREX) as Contrave is Back Up & Running

Sep 22, 2011 04:46 PM Needham & Company Maintains a 'Buy' on Vivus (VVUS); Risks Around Topiramate/Phentermine are Manageable

Sep 21, 2011 08:56 AM Brean Murray Carret & Co. Maintains a 'Sell' on Vivus; Orexigen (OREX) News Not Immediately Relevant to VVUS

Sep 21, 2011 07:58 AM JMP Securities Upgrades Orexigen Therapeutics (OREX) to Market Outperform

Sep 21, 2011 07:54 AM Lazard Capital Downgrades Orexigen Therapeutics (OREX) to Sell

Sep 21, 2011 07:27 AM Leerink Swann Upgrades Orexigen Therapeutics (OREX) to Outperform; Contrave Regulatory Path Unexpectedly Clarified

Jun 3, 2011 02:57 PM BofA/Merrill Lynch Cuts Orexigen (OREX) to Neutral Following Sell-Off

Apr 21, 2011 07:38 AM BofA/Merrill Lynch Upgrades Orexigen Therapeutics (OREX) to Buy

Feb 2, 2011 10:41 AM Canaccord Genuity Morning Coffee on Orexigen (OREX): Not Worth The Weight

Feb 2, 2011 08:15 AM Jefferies Downgrades Orexigen Therapeutics (OREX) to Hold, Value Limited Just Beyond Cash After Contrave Failure

Feb 1, 2011 12:51 PM Cowen Sees Orexigen (OREX) Raising $200M in Capital to Finish Contrave Study

Feb 1, 2011 10:06 AM Leerink Swann Downgrades Orexigen Therapeutics (OREX) to Market Perform; Contrave CRL Asks For CV Study Pre-Approval

Feb 1, 2011 09:59 AM Canaccord Genuity Downgrades Orexigen Therapeutics (OREX) to Hold; Worst Case Scenario Occurred

Feb 1, 2011 09:28 AM Orexigen (OREX) Shares Downgraded at JPMorgan, Leerink, Cowen; More Likely to Follow

Jan 31, 2011 02:14 PM Orexigen (OREX) Shares Surge Ahead of FDA Response for Contrave NDA

Jan 31, 2011 09:27 AM Canaccord Genuity maintains a 'Buy' on Orexigen Therapeutics (OREX); PDUFA Expected Today

Dec 14, 2010 09:13 AM Canaccord Genuity on Life Sciences/Biotechnology: BEST IDEAS FOR 2011: AMRN, DNDN, FOLD, NPSP, OREX, VRUS

Dec 9, 2010 10:56 AM Canaccord Genuity Reiterates a 'Buy' on Orexigen Therapeutics (OREX); Provides More Clarity on Contrave's Path Forward; Stock Has Room

Dec 8, 2010 10:46 AM Canaccord Genuity Reiterates a 'Buy' on Orexigen Therapeutics (OREX); OREX Shoots and Scores; FDA Panel Gives Contrave a Big Fat Yes

Dec 8, 2010 09:19 AM Jefferies Raises Price Target on Orexigen Therapeutics (OREX), Maintains Buy Rating

Dec 8, 2010 07:50 AM Needham & Company Reiterates a 'Buy' on Vivus (VVUS); Contrave FDA Advisory Committee Vote a Positive for Obesity Space, Qnexa, and Vivus

Dec 8, 2010 06:59 AM BofA/Merrill Lynch Upgrades Vivus (VVUS) Two-Notches to Buy

Dec 6, 2010 11:04 AM Canaccord Genuity Morning Coffee on Orexigen (OREX): Weighing in...

Dec 3, 2010 11:42 AM Rodman & Renshaw Downgrades Orexigen Therapeutics (OREX) to Underperform

Nov 30, 2010 10:52 AM Canaccord Genuity Reiterates a 'Buy/Top Pick' Rating on Orexigen Therapeutics (OREX); Buy Before 12/7 Ad Com

Back to OREX Stock Lookup